Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy

por Bhanegaonkar, Abhijeet, Pandya, Shivani, Zheng, Ying, Kim, Ruth, Krulewicz, Stan, Kasturi, Vijay, Phatak, Hemant
Publicado 2021

Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line the...

por Hutson, Thomas E, Liu, Frank X, Dieyi, Christopher, Kim, Ruth, Krulewicz, Stan, Kasturi, Vijay, Bhanegaonkar, Abhijeet
Publicado 2021

Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study

por Waterhouse, David, Iadeluca, Laura, Sura, Sneha, Wilner, Keith, Emir, Birol, Krulewicz, Stan, Espirito, Janet, Bartolome, Lauren
Publicado 2021

Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel

por Bhanegaonkar, Abhijeet, Liu, Frank X., Boyd, Marley, Fulcher, Nicole, Kim, Ruth, Krulewicz, Stan, Smith, Jodi, Cowey, C. Lance
Publicado 2021

Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase...

por Bilen, Mehmet A., Rini, Brian I., Voss, Martin H., Larkin, James, Haanen, John B.A.G., Albiges, Laurence, Pagliaro, Lance C., Voog, Eric G., Lam, Elaine T., Kislov, Nikolay, McGregor, Bradley A., Lalani, Aly-Khan A., Huang, Bo, di Pietro, Alessandra, Krulewicz, Stan, Robbins, Paul B., Choueiri, Toni K.
Publicado 2022